Morrell Michael Avram

Improving Prognosis for Kidney Disorders Morrell Michael Avram 2002 edition

Marc Notes: Papers from a conference sponsored by the Avram Center for Kidney Diseases, Long Island College Hospital.; Includes bibliographical references and index. Table of Contents: List of Principal Authors. Dedication. Introduction; M. M. Avram. 1. How to Achieve Maximal Protection in Non-Diabetic Chronic Renal Disease; M. W. Taal, B. M. Brenner. 2. Anemia of Chronic Kidney Disease and its Management with Recombinant Human Erythropoietin and Darbepoetin Alfa; A. R. Nissenson, E. M. Tong. 3. Cardiovascular Disease in Patients with Chronic Kidney Disease: The Causes and Effects; A. Levin, et al. 4. Metabolic Pathogenesis of Cardio-Renal Disease; W. F. Keane. 5. Oxidative Stress and Inflammation in Hemodialysis Patients; N. W. Levin, et al. 6. Prognostic Value of Enrollment Parathyroid Hormone in Hemodialysis and Peritoneal Dialysis Patients for Survival. A 14 Years Follow-up; 7. Prealbumin as an Important Predictor for Survival and Nutritional Status in Hemodialysis and Peritoneal Dialysis Patients; N. Mittman, et al. 8. How to Attain Optimal Antiproteinuric Dose of Losartan in Non-Diabetic Patients with Nephrotic Range Proteinuria; D. de Zeeuw, et al. 9. Hypoalbuminemia in the Patient with Renal Disease; G. A. Kaysen. 10. Kidney Disease and Mechanisms that Cause Loss of Muscle Mass; W. E. Mitch, S. R. Price. 11. Role of Plasma Homocysteine and Plasminogen Activator Inhibitor-1 in the Progression of Diabetic Nephropathy; 12. Effects of Erythropoietin (EPO) and Aminoguanidine (AG) on Deformability (df) in Diabetic Azotemic and Uremic Patients; E. A. Friedman, et al. 13. Characterization of the PKD1 Gene Product, Polycystin-1; 14. Nutrition and Blood Pressure; J. D. Kopple. 15. How to Minimize Bone Disease in Renal Failure; K. J. Martin, E. A. Gonzalez. Index."